Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

The Pretreatment Controlling Nutritional Status (CONUT) Score Is an Independent Prognostic Factor in Elderly Patients with Diffuse Large B-Cell Lymphoma

Yuto Kaneda, MD, Nobuhiro Kanemura, MD PhD, Nobuhiko Nakamura, MD PhD, Yoshikazu Ikoma, MD, Kimihiro Yamaguchi, MD, Takuro Matsumoto, MD PhD, Yuhei Shibata, MD PhD, Hiroshi Nakamura, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Senji Kasahara, MD PhD, Takeshi Hara, MD PhD, Masahito Shimizu, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2018) 132 (Supplement 1): 4210.

https://doi.org/10.1182/blood-2018-99-110055

Published: 2018

Journal Articles

Prospective PhaseⅡ Study of Reduced Toxicity Conditioning Consisted of High Dose-Cytarabine, Fludarabine, Cyclophosphamide +/- Total Body Irradiation Followed By Allogeneic Stem Cell Transplantation

Senji Kasahara, MD PhD, Hiroshi Nakamura, MD, Yuto Kaneda, MD, Yoshikazu Ikoma, MD, Eri Takada, MD, Kimihiro Yamaguchi, MD, Yuhei Shibata, MD PhD, Takuro Matsumoto, MDPhD, Nobuhiko Nakamura, MD PhD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Hideko Goto, MD PhD, Takeshi Hara, MD PhD, Michio Sawada, MD PhD, Takeshi Takahashi, MD PhD, Masahito Shimizu, MD PhD, Hisashi Tsurumi, MD

Blood (2017) 130 (Supplement 1): 1960.

https://doi.org/10.1182/blood.V130.Suppl_1.1960.1960

Published: 2017

Journal Articles

The Roles of Aryl Hydrocarbon Receptor in T Cells at IDO-Positive Tumor Microenvironment

Soranobu Ninomiya, MD PhD, Nobuhiko Nakamura, MD PhD, Junichi Kitagawa, MD PhD, Takeshi Hara, MD PhD, Masahito Shimizu, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2016) 128 (22): 3693.

https://doi.org/10.1182/blood.V128.22.3693.3693

Published: 2016

Journal Articles

Benefit of Consolidative Radiotherapy in Patients with Limited Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era

Nobuhiko Nakamura, MD PhD, Yoshikazu Ikoma, MD, Yuhei Shibata, MD PhD, Takuro Matsumoto, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2016) 128 (22): 4210.

https://doi.org/10.1182/blood.V128.22.4210.4210

Published: 2016

Journal Articles

The Value of Combination of Serum L-Kynurenine Level and Expression of Indoleamine 2,3-Dioxygenase mRNA As a Prognostic Factor in Acute Myeloid Leukemia

Hisashi Tsurumi, MD PhD, Takuro Matsumoto, MD, Yuhei Shibata, MD, Nobuhiko Nakamura, MD PhD, Hiroshi Nakamura, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Yasuhito Nannya, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD

Blood (2015) 126 (23): 4947.

https://doi.org/10.1182/blood.V126.23.4947.4947

Published: 2015

Journal Articles

Sarcopenia and Adipopenia Are Independent Prognostic Factors in Patients with Acute Myeloid Leukemia

Nobuhiko Nakamura, MD PhD, Yuhei Shibata, MD, Takuro Matsumoto, MD, Hiroshi Nakamura, MD, Junichi Kitagawa, MD PhD, Soranobu Ninomiya, MD PhD, Yasuhito Nannya, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2015) 126 (23): 4953.

https://doi.org/10.1182/blood.V126.23.4953.4953

Published: 2015

Journal Articles

The Incidence and the Risk Factors of Bowel Perforation Due to Chemotherapy in Gastrointestinal Diffuse Large B Cell Lymphoma

Takuro Matsumoto, MD, Yuhei Shibata, MD, Nobuhiko Nakamura, MD PhD, Hiroshi Nakamura, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Yasuhito Nannya, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2015) 126 (23): 1515.

https://doi.org/10.1182/blood.V126.23.1515.1515

Published: 2015

Journal Articles

A Comparison of THP- Cop and CHOP for Peripheral T-Cell Lymphoma, Not Otherwise Specified

Yuhei Shibata, MD, Nobuhiko Nakamura, MD PhD, Senji Kasahara, MD PhD, Toshiki Yamada, MD PhD, Michio Sawada, MD PhD, Takeshi Yoshikawa, MD PhD, Hiroshi Nakamura, MD, Junichi Kitagawa, MD PhD, Nobuhiro Kanemura, MD PhD, Naoe Goto, MD PhD, Takeshi Hara, MD PhD, Koshiro Saito, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2014) 124 (21): 3059.

https://doi.org/10.1182/blood.V124.21.3059.3059

Published: 2014

Journal Articles

A Randomized Phase II/III Study of R-THP-Cop Vs R-CHOP for Patients Younger Than 70 Years with DLBCL

Naoe Goto, MD PhD, Takuro Matsumoto, MD, Yuhei Shibata, MD, Junichi Kitagawa, MD PhD, Nobuhiro Kanemura, MD PhD, Yoshikawa Takeshi, MDPhD, Senji Kasahara, MD PhD, Hideko Goto, MDPhD, Kenji Fukuno, MD, Takeshi Hara, MD PhD, Toshiki Yamada, MD PhD, Michio Sawada, MD PhD, Takeshi Takahashi, MDPhD, Koshiro Saito, MD PhD, Hisataka Moriwaki, Prof., Hisashi Tsurumi, MD PhD

Blood (2014) 124 (21): 3078.

https://doi.org/10.1182/blood.V124.21.3078.3078

Published: 2014

Journal Articles

High Response Rate and Acceptable Toxicity of R-P-Imvp-16/CBDCA for Relapsed or Refractory Aggressive B-Cell Lymphoma

Takuro Matsumoto, MD, Nobuhiko Nakamura, MD PhD, Yuhei Shibata, MD, Hiroshi Nakamura, MD, Ryoko Mabuchi, MD, Junichi Kitagawa, MD PhD, Nobuhiro Kanemura, MD PhD, Naoe Goto, MD PhD, Senji Kasahara, MD PhD, Hideko Goto, MD PhD, Kenji Fukuno, MD PhD, Takeshi Hara, MD PhD, Toshiki Yamada, MD PhD, Michio Sawada, MD PhD, Takeshi Takahashi, MD PhD, Masami Oyama, MD PhD, Koshiro Saito, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2014) 124 (21): 4418.

https://doi.org/10.1182/blood.V124.21.4418.4418

Published: 2014

Journal Articles

Combination Of Indoleamine 2,3-Dioxygenase Inhibitor and Cytotoxic Agents Is a Novel Therapeutic Option For Non-Hodgkin Lymphoma

Nobuhiko Nakamura, MD, Takeshi Hara, MD, PhD, Yuhei Shibata, MD, Takuro Matsumoto, MD, Ryoko Mabuchi, MD, Hiroshi Nakamura, MD, Junichi Kitagawa, MD, PhD, Nobuhiro Kanemura, MD, PhD, Naoe Goto, MD, PhD, Masahito Shimizu, MD, PhD, Hisashi Tsurumi, MD, PhD, Hisataka Moriwaki

Blood (2013) 122 (21): 4408.

https://doi.org/10.1182/blood.V122.21.4408.4408

Published: 2013

Journal Articles

Prognositc Inpact of Tumor-Infiltrating FOXP3 + Regulatory T Cells in DLBCL Treated with R-CHOP

Naoe Goto, MD, PhD, Hisashi Tsurumi, MD, PhD, Yuhei Shibata, MD, Ryoko Mabuchi, MD, Nobuhiko Nakamura, MD, Hiroshi Nakamura, MD, Junichi Kitagawa, MD, Nobuhiro Kanemura, MD, PhD, Takeshi Hara, MD, PhD, Hisataka Moriwaki, Prof.

Blood (2012) 120 (21): 1555.

https://doi.org/10.1182/blood.V120.21.1555.1555

Published: 2012

Journal Articles

Serum IL-10 and IL-8 Among Variable Cytokines Derived From Helper T Cells Might Be Associated with Prognoses for Malignant Lymphoma Patients

Junichi Kitagawa, MD, PhD, Hisashi Tsurumi, MD, PhD, Naoe Goto, MD, PhD, Katsuyoshi Takata, MD, PhD, Nobuhiko Nakamura, MD, Nobuhiro Kanemura, MD, PhD, Takeshi Hara, MD, PhD, Senji Kasahara, MD, PhD, Takeshi Takahashi, MD, PhD, Tadashi Yoshino, Prof., Hisataka Moriwaki, Prof.

Blood (2012) 120 (21): 5107.

https://doi.org/10.1182/blood.V120.21.5107.5107

Published: 2012

Journal Articles

A Phase II Study of the Combination Chemotherapy Consisted of Rituximab and THP-COP Regimen as First-Line Treatment for Patients with Diffuse Large B-Cell Lymphoma

Hisashi Tsurumi, MD, PhD, Naoe Goto, Takeshi Hara, Senji Kasahara, Nobuhiro Kanemura, Junichi Kitagawa, MD, Takeshi Yoshikawa, Toshiki Yamada, Michio Sawada, Takeshi Takahashi, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2008) 112 (11): 3599.

https://doi.org/10.1182/blood.V112.11.3599.3599

Published: 2008

NARROW

The Pretreatment Controlling Nutritional Status (CONUT) Score Is an Independent Prognostic Factor in Elderly Patients with Diffuse Large B-Cell Lymphoma

Prospective PhaseⅡ Study of Reduced Toxicity Conditioning Consisted of High Dose-Cytarabine, Fludarabine, Cyclophosphamide +/- Total Body Irradiation Followed By Allogeneic Stem Cell Transplantation

The Roles of Aryl Hydrocarbon Receptor in T Cells at IDO-Positive Tumor Microenvironment

Benefit of Consolidative Radiotherapy in Patients with Limited Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era

The Value of Combination of Serum L-Kynurenine Level and Expression of Indoleamine 2,3-Dioxygenase mRNA As a Prognostic Factor in Acute Myeloid Leukemia

Sarcopenia and Adipopenia Are Independent Prognostic Factors in Patients with Acute Myeloid Leukemia

The Incidence and the Risk Factors of Bowel Perforation Due to Chemotherapy in Gastrointestinal Diffuse Large B Cell Lymphoma

A Comparison of THP- Cop and CHOP for Peripheral T-Cell Lymphoma, Not Otherwise Specified

A Randomized Phase II/III Study of R-THP-Cop Vs R-CHOP for Patients Younger Than 70 Years with DLBCL

High Response Rate and Acceptable Toxicity of R-P-Imvp-16/CBDCA for Relapsed or Refractory Aggressive B-Cell Lymphoma

Combination Of Indoleamine 2,3-Dioxygenase Inhibitor and Cytotoxic Agents Is a Novel Therapeutic Option For Non-Hodgkin Lymphoma

Prognositc Inpact of Tumor-Infiltrating FOXP3 + Regulatory T Cells in DLBCL Treated with R-CHOP

Serum IL-10 and IL-8 Among Variable Cytokines Derived From Helper T Cells Might Be Associated with Prognoses for Malignant Lymphoma Patients

A Phase II Study of the Combination Chemotherapy Consisted of Rituximab and THP-COP Regimen as First-Line Treatment for Patients with Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only